var data={"title":"Clinical manifestations and diagnosis of aneurysmal subarachnoid hemorrhage","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical manifestations and diagnosis of aneurysmal subarachnoid hemorrhage</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Robert J Singer, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Christopher S Ogilvy, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Guy Rordorf, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Jose Biller, MD, FACP, FAAN, FAHA</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/contributors\" class=\"contributor contributor_credentials\">Janet L Wilterdink, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Sep 26, 2013.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Twenty percent of strokes are hemorrhagic, with subarachnoid hemorrhage (SAH) and intracerebral hemorrhage each accounting for 10 percent. Most SAHs are caused by ruptured saccular aneurysms. This is often a devastating clinical event with mortality rates that approach 50 percent, as well as substantial neurologic morbidity in survivors.</p><p>Mortality rates due to SAH appear to be decreasing over time in Western populations [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/1-4\" class=\"abstract_t\">1-4</a>]. Improvements in rates of smoking, treatment of hypertension, and management of SAH are plausible but unproven reasons for the reduction in mortality. Improved diagnostic accuracy over time, including exclusion of SAH mimics, as well as therapeutic advances may also be playing a role</p><p>The epidemiology, etiology, clinical manifestations, and diagnosis of aneurysmal SAH are reviewed here. The treatment of this disorder and the epidemiology and pathogenesis of intracranial aneurysms and management of unruptured aneurysms are discussed separately. Mycotic aneurysms and nonaneurysmal subarachnoid hemorrhage are also discussed separately. (See <a href=\"topic.htm?path=aneurysmal-subarachnoid-hemorrhage-epidemiology-risk-factors-and-pathogenesis\" class=\"medical medical_review\">&quot;Aneurysmal subarachnoid hemorrhage: Epidemiology, risk factors, and pathogenesis&quot;</a> and <a href=\"topic.htm?path=treatment-of-aneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">&quot;Treatment of aneurysmal subarachnoid hemorrhage&quot;</a> and <a href=\"topic.htm?path=unruptured-intracranial-aneurysms\" class=\"medical medical_review\">&quot;Unruptured intracranial aneurysms&quot;</a> and <a href=\"topic.htm?path=overview-of-infected-mycotic-arterial-aneurysm\" class=\"medical medical_review\">&quot;Overview of infected (mycotic) arterial aneurysm&quot;</a> and <a href=\"topic.htm?path=nonaneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">&quot;Nonaneurysmal subarachnoid hemorrhage&quot;</a> and <a href=\"topic.htm?path=perimesencephalic-nonaneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">&quot;Perimesencephalic nonaneurysmal subarachnoid hemorrhage&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">CLINICAL PRESENTATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The primary symptom of aneurysmal SAH is a sudden, severe headache (97 percent of cases) classically described as the &quot;worst headache of my life&quot; [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/5\" class=\"abstract_t\">5</a>]. The headache is lateralized in 30 percent of patients, predominantly to the side of the aneurysm. Consistent with the rapid spread of blood, the symptoms of SAH typically begin abruptly.</p><p>The onset of the headache may or may not be associated with a brief loss of consciousness, nausea or vomiting, and meningismus &#160; In one series, these occurred in 53, 77, and 35 percent of patients respectively [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/6\" class=\"abstract_t\">6</a>]. Meningismus and often lower back pain may not develop until several hours after the bleed since it is caused by the breakdown of blood products within the CSF, which lead to an aseptic meningitis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/7\" class=\"abstract_t\">7</a>]. While many patients have an altered level of consciousness, coma is unusual. Seizures occur during the first 24 hours in less than 10 percent of patients, but are a predictor of poor outcome [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/8\" class=\"abstract_t\">8</a>]. SAH may also present as sudden death; at least 10 to 15 percent of patients die before reaching the hospital.</p><p>The complaint of the sudden onset of severe headache is sufficiently characteristic that a SAH should always be considered. In a prospective study of 148 patients presenting with sudden and severe headache, for example, SAH was present in 25 percent overall and in 12 percent of those in whom headache was the only symptom [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/9\" class=\"abstract_t\">9</a>]. Similar findings were noted in another report in which 20 of 107 patients with the &quot;worst headache of my life&quot; had an SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/10\" class=\"abstract_t\">10</a>].</p><p>The combination of vitreous (preretinal) hemorrhages with SAH is known as Terson's syndrome and implies a poorer prognosis. In a systematic review, patients with Terson's syndrome had higher Hunt and Hess grades (<a href=\"image.htm?imageKey=NEURO%2F69179\" class=\"graphic graphic_table graphicRef69179 \">table 1</a>) and significantly higher mortality than those without [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/11\" class=\"abstract_t\">11</a>]. The preretinal hemorrhages of Terson's syndrome may indicate a more abrupt increase in intracranial pressure and must be distinguished from the more benign retinal hemorrhages sometimes associated with SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Approximately 30 to 50 percent of patients report a history of a sudden and severe headache (the sentinel headache) that precedes a major SAH by 6 to 20 days [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/5\" class=\"abstract_t\">5</a>]. These are felt to represent a minor hemorrhage or &ldquo;warning leak&rdquo;. A systematic literature review through September 2002 found that the incidence of sentinel headaches in aneurysmal SAH ranged from 10 to 43 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/13\" class=\"abstract_t\">13</a>]. </p><p>While the occurrence of symptoms in the setting of physical exertion or emotional stress suggests SAH, about half of aneurysmal SAH occur during nonstrenuous activity, rest, or sleep [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/14\" class=\"abstract_t\">14</a>]. (See <a href=\"topic.htm?path=aneurysmal-subarachnoid-hemorrhage-epidemiology-risk-factors-and-pathogenesis#H1387172632\" class=\"medical medical_review\">&quot;Aneurysmal subarachnoid hemorrhage: Epidemiology, risk factors, and pathogenesis&quot;, section on 'Pathogenesis'</a>.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h1\">DIAGNOSIS OF SUBARACHNOID HEMORRHAGE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sudden-onset headache, regardless of severity or prior headache history, should raise the clinical suspicion for subarachnoid hemorrhage (SAH) and compel a diagnostic evaluation [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/15\" class=\"abstract_t\">15</a>]. Altered consciousness, collapse or vomiting at onset, meningismus, preretinal subhyaloid hemorrhages, and a paucity of lateralizing neurologic signs are additional features that are characteristic of SAH. In patients with a suspicious history, the first step is to determine the presence of SAH, followed by an evaluation for the cause of hemorrhage.</p><p>Noncontrast head computed tomography (CT), with or without lumbar puncture, is the mainstay of diagnosis of SAH. A negative head CT and lumbar puncture effectively eliminate the diagnosis of SAH as long as both tests are performed within a few days of the event [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/16\" class=\"abstract_t\">16</a>]. Nevertheless, cerebral angiography should be considered if diagnostic doubt remains.</p><p>Misdiagnosis of SAH is not infrequent, and usually results from three common errors [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/17\" class=\"abstract_t\">17</a>]:</p><p><ul class=\"bullet-block\"><li>Failure to appreciate the spectrum of clinical presentation associated with SAH (see <a href=\"#H12\" class=\"local\">'Clinical presentation'</a> above)</li><li>Failure to obtain a head CT scan or to understand its limitations in diagnosing SAH (see <a href=\"#H27\" class=\"local\">'Head CT scan'</a> below)</li><li>Failure to perform a lumbar puncture and correctly interpret the results (see <a href=\"#H28\" class=\"local\">'Lumbar puncture'</a> below)</li></ul></p><p>In a hospital-based series of 482 patients admitted with SAH, initial misdiagnosis occurred in 12 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/18\" class=\"abstract_t\">18</a>]. Misdiagnosis was independently associated with small SAH volume, normal mental status at presentation, and right-sided aneurysm location. Failure to obtain a head CT scan at initial contact was the most common error, occurring in 73 percent of misdiagnosed patients. Among SAH patients with normal mental status at first contact (45 percent), the misdiagnosis rate rose to 20 percent and was associated with a nearly four-fold increase in mortality at 12 months as well as increased morbidity among survivors.</p><p>Delays in diagnosis of SAH are also common, even in patients with a characteristic history, leading to delays in treatment in 25 percent of patients that can worsen outcome [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/19,20\" class=\"abstract_t\">19,20</a>].</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h2\">Head CT scan</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The cornerstone of SAH diagnosis is the noncontrast head CT scan [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/20,21\" class=\"abstract_t\">20,21</a>]. Clot is demonstrated in the subarachnoid space in 92 percent of cases if the scan is performed within 24 hours of the bleed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/21,22\" class=\"abstract_t\">21,22</a>]. Intracerebral extension is present in 20 to 40 percent of patients and intraventricular and subdural blood may be seen in 15 to 35 and 2 to 5 percent, respectively. The head CT scan should be performed with thin cuts through the base of the brain to increase the sensitivity to small amounts of blood [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/23\" class=\"abstract_t\">23</a>].</p><p>The sensitivity of head CT for detecting SAH is highest in the first 6 to 12 hours after SAH (nearly 100 percent) and then progressively declines over time to about 58 percent at day five [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/21,22,24-26\" class=\"abstract_t\">21,22,24-26</a>]. Because the consequences of missing SAH are potentially dire, most guidelines mandate a followup lumbar puncture when the CT scan is negative [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/27\" class=\"abstract_t\">27</a>]. Some studies and experts suggest that the sensitivity of CT when performed within six hours of the onset of symptoms is sufficiently sensitive (100 percent) to make a follow-up LP unnecessary [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/22,28,29\" class=\"abstract_t\">22,28,29</a>]. There are important caveats that suggest that this approach may not be generally applicable. One is that such studies are performed in centers where CT scans are generally interpreted by expert reviewers. Another is that the sensitivity of CT may be reduced, when symptoms are atypical, such as isolated neck pain. The sensitivity of head CT is also reduced with more minor bleeds; in one study, for example, a minor SAH was not diagnosed by CT scan in 55 percent of patients; lumbar puncture was positive in all cases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/30\" class=\"abstract_t\">30</a>]. </p><p>The distribution of blood on CT (performed within 72 hours after the bleed) is a poor predictor of the site of an aneurysm except in patients with ruptured anterior cerebral artery or anterior communicating artery aneurysms and in patients with a parenchymal hematoma [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/31\" class=\"abstract_t\">31</a>].</p><p class=\"headingAnchor\" id=\"H1387169153\"><span class=\"h2\">Brain MRI</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Limited data suggest that proton density and FLAIR sequences on brain MRI may be as sensitive as head CT for the acute detection of SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/32\" class=\"abstract_t\">32</a>]. In addition, FLAIR and T2 sequences on MRI have a high sensitivity in patients with a subacute presentation of SAH (eg, &gt;4 days from the bleed) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/33\" class=\"abstract_t\">33</a>]. However, as with a negative CT scan, lumbar puncture should follow a negative MRI if a patient suspected to have SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/27\" class=\"abstract_t\">27</a>].</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Lumbar puncture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lumbar puncture (LP) is mandatory if there is a strong suspicion of SAH despite a normal head CT [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/20,27\" class=\"abstract_t\">20,27</a>]. Clinical prediction rules are NOT sufficiently sensitive to exclude SAH without a lumbar puncture [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/34\" class=\"abstract_t\">34</a>]. (See <a href=\"#H27\" class=\"local\">'Head CT scan'</a> above.)</p><p>The classic findings of SAH are an elevated opening pressure and an elevated red blood cell (RBC) count that does not diminish from CSF tube one to tube four. The differential of RBC between tubes one and four, and immediate centrifugation of the CSF can help differentiate bleeding in SAH from that due to a traumatic spinal tap:</p><p><ul class=\"bullet-block\"><li><strong>Clearing of blood</strong> &mdash; Clearing of blood (a declining RBC count with successive collection tubes) is purported to be a useful way of distinguishing a traumatic LP from SAH. However, this is an unreliable sign of a traumatic tap, since a decrease in the number of RBCs in later tubes can also occur in SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/35\" class=\"abstract_t\">35</a>]. This method can reliably exclude SAH only if there is substantial RBC count in the first tube, and the late or final collection tube is normal. One study found that the percent change in RBC count between the first and last tubes was more useful than the absolute difference as a test for distinguishing traumatic tap from SAH; the optimal test threshold based on this sample was a 63 percent reduction in the RBC count [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/36\" class=\"abstract_t\">36</a>]. These findings require independent confirmation.</li><li><strong>Xanthochromia</strong> &mdash; Xanthochromia (pink or yellow tint) represents hemoglobin degradation products. An otherwise unexplained xanthochromic supernatant in CSF is highly suggestive of SAH. Xanthochromia may be visually detected by comparing a vial of CSF with a vial of plain water held side by side against a white background in bright light [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/37\" class=\"abstract_t\">37</a>]. The presence of xanthochromia indicates that blood has been in the CSF for at least two hours; therefore if the CSF is analyzed quickly after a traumatic LP, there will not be xanthochromia. However, if LP is performed within two hours after the onset of SAH, xanthochromia may similarly be absent; the absence of xanthochromia cannot be used as evidence of a traumatic tap if an LP is performed in a SAH of less than two hours duration. For a LP performed several hours after the ictus, a finding of erythrocytosis without xanthochromia is unlikely to be SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/38\" class=\"abstract_t\">38</a>]. Xanthochromia can last for two weeks or more [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/39,40\" class=\"abstract_t\">39,40</a>]. <br/><br/>One retrospective study identified 117 adults with no known history of aneurysm or previous SAH who presented to the emergency room with thunderclap headache [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/41\" class=\"abstract_t\">41</a>]. All had a negative noncontrast head CT followed by LP. Xanthochromic CSF was found by visual inspection in 18 patients (15 percent). Those patients then had four-vessel catheter angiography, which detected a ruptured cerebral aneurysm in 13 (72 percent). One patient with no xanthochromia had an elevated red blood cell count <span class=\"nowrap\">(&ge;20,000/microL)</span> in four successive collection tubes and a ruptured aneurysm by angiography. In this series, xanthochromia for the detection of cerebral aneurysms had a sensitivity and specificity of 93 and 95 percent.<br/><br/>Other conditions that can produce xanthochromia include increased CSF concentrations of protein (150 <span class=\"nowrap\">mg/dL),</span> systemic hyperbilirubinemia (serum bilirubin &gt;10 to 15 <span class=\"nowrap\">mg/dL),</span> and traumatic lumbar puncture with more than 100,000 red blood <span class=\"nowrap\">cells/microL</span>. (See <a href=\"topic.htm?path=cerebrospinal-fluid-physiology-and-utility-of-an-examination-in-disease-states#H9\" class=\"medical medical_review\">&quot;Cerebrospinal fluid: Physiology and utility of an examination in disease states&quot;, section on 'Xanthochromia'</a>.)</li><li><strong>Spectrophotometry</strong> &mdash; Spectrophotometry detects blood breakdown products as they progress from oxyhemoglobin to methemoglobin and finally to bilirubin [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/10,39,42\" class=\"abstract_t\">10,39,42</a>]. Bilirubin concentration peaks about 48 hours after SAH onset, and it may last as long as four weeks after major SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/43\" class=\"abstract_t\">43</a>]. While CSF spectrophotometry is more sensitive than visual inspection for xanthochromia, it is not universally recommended. As a practical matter, spectrophotometry is rarely available in North American hospitals.<br/><br/>The sample of CSF to be tested by spectrophotometry should be the one that contains the least amount of blood staining. It should be protected from light and sent immediately to the laboratory for analysis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/39,43\" class=\"abstract_t\">39,43</a>].<br/><br/>Spectrophotometry for detection of bilirubin is highly sensitive (&gt;95 percent) when LP is done at least 12 hours after SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/40\" class=\"abstract_t\">40</a>]. Although xanthochromia is generally identified by visual inspection, laboratory confirmation with CSF spectrophotometry is more sensitive and is recommended by some experts, if available [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/39,43-46\" class=\"abstract_t\">39,43-46</a>]. In one study, 11 analysts compared xanthochromic CSF samples using visual and spectrophotometric analysis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/45\" class=\"abstract_t\">45</a>]. The spectrophotometric detection of bilirubin was significantly higher than visual detection in conditions where CSF samples were contaminated by presence of hemolyzed blood, or when CSF samples contained low levels of bilirubin. <br/><br/>Despite a higher sensitivity than visual inspection for the detection of xanthochromia, CSF spectrophotometry has only a low to moderate specificity for the diagnosis of SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/47\" class=\"abstract_t\">47</a>].</li></ul></p><p class=\"headingAnchor\" id=\"H1412261260\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>While aneurysmal SAH is always the primary consideration when a patient presents with an abrupt onset headache, a number of other conditions, some serious and some benign, can cause a similar presentation (<a href=\"image.htm?imageKey=NEURO%2F81710\" class=\"graphic graphic_table graphicRef81710 \">table 2</a>). These are discussed in detail separately. (See <a href=\"topic.htm?path=approach-to-the-patient-with-thunderclap-headache\" class=\"medical medical_review\">&quot;Approach to the patient with thunderclap headache&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H34\"><span class=\"h1\">IDENTIFYING THE ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Once a diagnosis of SAH has been made, the etiology of the hemorrhage must be determined with angiographic studies. Of the available tests, digital subtraction angiography (DSA) is believed to have the highest resolution to detect intracranial aneurysms and define their anatomic features and remains the gold standard test for this indication [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/27,48\" class=\"abstract_t\">27,48</a>].</p><p class=\"headingAnchor\" id=\"H35\"><span class=\"h2\">Digital subtraction angiography</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most ruptured aneurysms can be readily identified using standard cross-sectional imaging techniques coupled with DSA that includes injections of bilateral vertebral and internal carotid arteries, as well as the external carotid circulation and deep cervical branches, which may supply a cryptic dural arteriovenous fistula. Angiographic demonstration of key branch points, including the proximal posterior circulation, is essential to definitively rule out aneurysm.</p><p>The morbidity of DSA in patients with SAH is relatively low. In a meta-analysis of three prospective studies, for example, the combined risk of permanent and transient neurologic complications was significantly lower in patients with SAH compared with those with a TIA or stroke (1.8 versus 3.7 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/49\" class=\"abstract_t\">49</a>].</p><p class=\"headingAnchor\" id=\"H36\"><span class=\"h2\">CT and MR angiography</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CT angiography (CTA) and magnetic resonance angiography (MRA) are noninvasive tests that are useful for screening and presurgical planning. Both CTA and MRA can identify aneurysms 3 to 5 mm or larger with a high degree of sensitivity [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/50\" class=\"abstract_t\">50</a>], but they do not achieve the resolution of conventional angiography. The sensitivity of CTA for the detection of ruptured aneurysms, using conventional angiography or digital subtraction angiography as the gold standard, is 83 to 98 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/51-57\" class=\"abstract_t\">51-57</a>]. Small aneurysms, in particular may not be reliably identified. If CTA does not reveal an aneurysm in a patient with SAH, DSA should be performed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/27\" class=\"abstract_t\">27</a>].</p><p>As technology improves, the sensitivity and specificity of noninvasive imaging is also likely to improve. [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/58\" class=\"abstract_t\">58</a>]. A 2011 meta-analysis of CTA diagnosis of intracranial aneurysms found that, compared with single-detector CTA, use of multidetector CTA was associated with an overall improved sensitivity and specificity for aneurysm detection (both &gt;97 percent) as well as improved detection of smaller aneurysms &le;4 mm in diameter [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/59\" class=\"abstract_t\">59</a>]. Another systematic review and meta-analysis restricted to patients with SAH had similar findings [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/60\" class=\"abstract_t\">60</a>].</p><p>A major advantage of CTA over conventional angiography is the speed and ease by which it can be obtained, often immediately after the diagnosis of SAH is made by head CT when the patient is still in the scanner. CTA is increasingly used as an alternative to angiography in many patients with SAH, thereby avoiding the need for conventional angiography [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/61,62\" class=\"abstract_t\">61,62</a>], and is particularly useful in the acute setting in a rapidly declining patient who needs emergent craniotomy for hematoma evacuation. Furthermore, CTA offers a more practical approach to acute diagnosis than MRA, given the constraints of acute patient management.</p><p>While a &ldquo;spot sign&rdquo; on CTA is associated with risk of hemorrhage expansion or rebleeding in patients with intracerebral hemorrhage, this is not the case for SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/63,64\" class=\"abstract_t\">63,64</a>]. It is likely that this sign, while appearing similar, actually reflects different processes when observed in SAH versus intracerebral hemorrhage. &#160;</p><p class=\"headingAnchor\" id=\"H59949337\"><span class=\"h2\">Patients with negative angiography</span></p><p class=\"headingAnchor\" id=\"H59950365\"><span class=\"h3\">Repeat angiography</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>No angiographic cause of SAH is evident in 14 to 22 percent of cases. It is critical to repeat the angiogram in 4 to 14 days if the initial angiogram is negative. The recommended followup test in this setting is usually digital subtraction angiography. Up to 24 percent of all SAH patients with initial negative angiography have an aneurysm found on repeat angiography [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/65-69\" class=\"abstract_t\">65-69</a>]. This may increase to as much as 49 percent if patients with perimesencephalic SAH and patients with normal CT scans are excluded [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/66\" class=\"abstract_t\">66</a>]. <br/><br/>Reasons for an initial false-negative angiogram include technical or reading errors, small aneurysm size, and obscuration of the aneurysm because of vasospasm, hematoma, or thrombosis within the aneurysm [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/65,66,70,71\" class=\"abstract_t\">65,66,70,71</a>]. A third angiogram at a period of two to three months is advocated by some, but is probably not necessary, if the initial two studies are felt to be well-performed and expertly reviewed. (See <a href=\"topic.htm?path=nonaneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">&quot;Nonaneurysmal subarachnoid hemorrhage&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H37\"><span class=\"h3\">Perimesencephalic hemorrhage</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some patients with an initially negative angiogram have blood in the cisterns around the midbrain, which reflects a perimesencephalic pattern of hemorrhage (<a href=\"image.htm?imageKey=NEURO%2F72476\" class=\"graphic graphic_diagnosticimage graphicRef72476 \">image 1</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/71-73\" class=\"abstract_t\">71-73</a>]. </p><p>Perimesencephalic hemorrhage accounts for about 10 percent of all cases of SAH. Most patients with perimesencephalic hemorrhage do not have an aneurysm or other defined etiology. This pattern is associated with a more favorable prognosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/73\" class=\"abstract_t\">73</a>]. </p><p>Repeat angiography is probably not necessary in patients with perimesencephalic hemorrhage [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/71\" class=\"abstract_t\">71</a>]. One study suggested that angiography may be avoided altogether if CT angiography excludes the presence of a vertebrobasilar aneurysm in patients with a perimesencephalic pattern of hemorrhage on unenhanced CT [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/74\" class=\"abstract_t\">74</a>]. A decision analysis supported omitting invasive angiography in these individuals [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/75\" class=\"abstract_t\">75</a>].</p><p>Perimesencephalic hemorrhage is discussed in detail separately. (See <a href=\"topic.htm?path=perimesencephalic-nonaneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">&quot;Perimesencephalic nonaneurysmal subarachnoid hemorrhage&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H38\"><span class=\"h3\">Other tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A minority of SAH is nonaneurysmal. The causes of these hemorrhages are diverse and include vascular malformations, arterial dissection as well as a variety of other etiologies. Further evaluation in such patients should include brain and spine MRI, This topic is discussed separately. (See <a href=\"topic.htm?path=nonaneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">&quot;Nonaneurysmal subarachnoid hemorrhage&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1387169359\"><span class=\"h1\">GRADING SEVERITY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of grading systems are used in practice to standardize the clinical classification of patients with SAH based upon the initial neurologic examination. The grading system proposed by Hunt and Hess (<a href=\"image.htm?imageKey=NEURO%2F69179\" class=\"graphic graphic_table graphicRef69179 \">table 1</a>) and that of the World Federation of Neurological Surgeons (WFNS) (<a href=\"image.htm?imageKey=NEURO%2F65468\" class=\"graphic graphic_table graphicRef65468 \">table 3</a>) are among the most widely used. The WFNS system incorporates the Glasgow Coma scale (<a href=\"image.htm?imageKey=NEURO%2F81854\" class=\"graphic graphic_table graphicRef81854 \">table 4</a>) combined with the presence of motor deficit.</p><p>The Fisher grade is an index of vasospasm risk based upon a CT-defined hemorrhage pattern (<a href=\"image.htm?imageKey=NEURO%2F81122\" class=\"graphic graphic_table graphicRef81122 \">table 5</a>), and the Claassen grading system is a similar index of the risk of delayed cerebral ischemia due to vasospasm (<a href=\"image.htm?imageKey=NEURO%2F57558\" class=\"graphic graphic_table graphicRef57558 \">table 6</a>).</p><p>A system proposed by Ogilvy and Carter stratifies patients based upon age, Hunt and Hess grade, Fisher grade, and aneurysm size (<a href=\"image.htm?imageKey=NEURO%2F70705\" class=\"graphic graphic_table graphicRef70705 \">table 7</a>). In addition to predicting outcome, this scale more accurately substratifies patients for therapy.</p><p>Grading scales for subarachnoid hemorrhage are discussed in greater detail separately. (See <a href=\"topic.htm?path=subarachnoid-hemorrhage-grading-scales\" class=\"medical medical_review\">&quot;Subarachnoid hemorrhage grading scales&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1387166640\"><span class=\"h1\">COMPLICATIONS AND CLINICAL COURSE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subarachnoid hemorrhage (SAH) is associated with a high mortality rate [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/58\" class=\"abstract_t\">58</a>]. A systematic review found that the average case fatality rate for SAH was 51 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/76\" class=\"abstract_t\">76</a>]. Approximately 10 percent of patients with aneurysmal SAH die prior to reaching the hospital, 25 percent die within 24 hours of SAH onset, and about 45 percent die within 30 days [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/77\" class=\"abstract_t\">77</a>].</p><p class=\"headingAnchor\" id=\"H1387166686\"><span class=\"h2\">Rebleeding</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rebleeding occurs in 8 to 23 percent of patients. Most studies have found that the risk of rebleeding is highest in the first 24 hours after SAH, particularly within six hours of the initial hemorrhage [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/78-81\" class=\"abstract_t\">78-81</a>]. Factors that may be independent predictors of rebleeding include:</p><p><ul class=\"bulletCompact-block\"><li>the Hunt-Hess grade on admission [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/79,80\" class=\"abstract_t\">79,80</a>]</li><li>maximal aneurysm diameter [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/80,82\" class=\"abstract_t\">80,82</a>]</li><li>a higher initial blood pressure [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/48\" class=\"abstract_t\">48</a>]</li><li>a sentinel headache preceding SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/83\" class=\"abstract_t\">83</a>]</li><li>a longer interval from ictus to admission [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/48\" class=\"abstract_t\">48</a>]</li><li>early ventriculostomy (prior to aneurysm treatment) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/48\" class=\"abstract_t\">48</a>]</li></ul></p><p>Rebleeding is usually diagnosed on the basis of an acute deterioration of neurologic status accompanied by appearance of new hemorrhage on head CT scan. Lumbar puncture is harder to evaluate because xanthochromia can persist for two weeks or more. (See <a href=\"#H28\" class=\"local\">'Lumbar puncture'</a> above.)</p><p>Only aneurysm treatment is effective for the prevention of rebleeding. (See <a href=\"topic.htm?path=treatment-of-aneurysmal-subarachnoid-hemorrhage#H259178626\" class=\"medical medical_review\">&quot;Treatment of aneurysmal subarachnoid hemorrhage&quot;, section on 'Aneurysm treatment'</a>.)</p><p>Rebleeding is associated with a higher rate of other complications and worse outcomes [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/82\" class=\"abstract_t\">82</a>]. The mortality associated with rebleeding is reported to be as high as 70 percent. (See <a href=\"topic.htm?path=treatment-of-aneurysmal-subarachnoid-hemorrhage#H24\" class=\"medical medical_review\">&quot;Treatment of aneurysmal subarachnoid hemorrhage&quot;, section on 'Management of complications'</a>.)</p><p class=\"headingAnchor\" id=\"H1387166692\"><span class=\"h2\">Vasospasm and delayed cerebral ischemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Delayed cerebral ischemia (DCI) is a frequent complication of SAH and one that contributes substantially to morbidity and mortality after SAH. Radiographic evidence of DCI occurs in 40 to 60 percent of patients with SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/84-87\" class=\"abstract_t\">84-87</a>]. In one case series of 56 patients with DCI, the two most common patterns of infarction were single cortical infarcts, typically located near the site of the ruptured aneurysm, and multiple widespread infarcts, often involving bilateral and subcortical regions and frequently located distal to the ruptured aneurysm, seen in 40 and 50 percent of patients respectively [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/87\" class=\"abstract_t\">87</a>]. Hypodense lesions on CT consistent with infarction appear to be more likely with larger volume SAH and poor initial clinical condition [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/84-86,88-92\" class=\"abstract_t\">84-86,88-92</a>]. Younger patients (&lt;55 years) and those who smoke appear to be at higher risk of DCI.</p><p>DCI is typically manifest by neurologic deterioration in level of consciousness or new focal neurologic deficits. However, in patients with poor clinical grade, DCI may be clinically silent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/93\" class=\"abstract_t\">93</a>]. </p><p>The most common cause of DCI after SAH is assumed to be vasospasm [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/94\" class=\"abstract_t\">94</a>]. Vasospasm causes symptomatic ischemia and infarction in approximately 20 to 30 percent of patients with aneurysmal SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/95,96\" class=\"abstract_t\">95,96</a>]. The severity of symptoms depends upon the artery affected and the degree of collateral circulation. Vasospasm typically begins no earlier than day three after hemorrhage, reaching a peak at days seven to eight. However, vasospasm can occur earlier, even at the time of hospital admission [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/97-100\" class=\"abstract_t\">97-100</a>]. Vasospasm is believed to be produced by spasmogenic substances generated during the lysis of subarachnoid blood. (See <a href=\"topic.htm?path=aneurysmal-subarachnoid-hemorrhage-epidemiology-risk-factors-and-pathogenesis#H1387172632\" class=\"medical medical_review\">&quot;Aneurysmal subarachnoid hemorrhage: Epidemiology, risk factors, and pathogenesis&quot;, section on 'Pathogenesis'</a>.)</p><p>Risk factors for vasospasm include the severity of bleeding and its proximity to the major intracerebral blood vessels. The location and extent of blood on computed tomography (CT) scan can help predict the likelihood of complicating cerebral vasospasm [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/101-103\" class=\"abstract_t\">101-103</a>]. In one series, severe vasospasm was correctly predicted and localized in 20 of 22 patients using the CT criteria of clots larger than 3 x 5 mm or layers of blood more than 1 mm thick [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/102\" class=\"abstract_t\">102</a>]. Radiologic grading scales including those of Fisher (<a href=\"image.htm?imageKey=NEURO%2F81122\" class=\"graphic graphic_table graphicRef81122 \">table 5</a>) and Claassen (<a href=\"image.htm?imageKey=NEURO%2F57558\" class=\"graphic graphic_table graphicRef57558 \">table 6</a>) are often used to predict the likelihood of vasospasm and cerebral ischemia. (See <a href=\"topic.htm?path=subarachnoid-hemorrhage-grading-scales\" class=\"medical medical_review\">&quot;Subarachnoid hemorrhage grading scales&quot;</a>.)</p><p>Other factors that may increase the risk of vasospasm include age less than 50 years and hyperglycemia [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/104,105\" class=\"abstract_t\">104,105</a>]. Most [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/106-108\" class=\"abstract_t\">106-108</a>] but not all [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/104\" class=\"abstract_t\">104</a>] studies have found that poor clinical grade (eg, Hunt-Hess grade 4 or 5, or Glasgow Coma Scale score &lt;14) is associated with an increased risk of vasospasm. In contrast, the type of therapy chosen (surgical versus endovascular) does not appear to influence risk. Patients exposed to statins and selective serotonin reuptake inhibitors (SSRIs) may also have a higher risk for vasospasm, according to a retrospective cohort study [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/108\" class=\"abstract_t\">108</a>]. The increased risk of vasospasm with statin use may be related to rebound effects from statin discontinuation at the time of SAH, as there is some evidence that statins may be useful for the prevention of vasospasm after SAH. (See <a href=\"topic.htm?path=treatment-of-aneurysmal-subarachnoid-hemorrhage#H15\" class=\"medical medical_review\">&quot;Treatment of aneurysmal subarachnoid hemorrhage&quot;, section on 'Statins'</a>.)</p><p>Mechanisms other than vasospasm may contribute to DCI. In one study, 19 percent of patients with vasospasm attributed-CT hypodensities had only mild or no vasospasm [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/109\" class=\"abstract_t\">109</a>]. Hypovolemia may add to the risk of cerebral ischemia in the setting of vasospasm, especially in the setting of impaired cerebrovascular autoregulation which appears to be evident after SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/110-112\" class=\"abstract_t\">110-112</a>]. Other mechanisms of ischemia include occlusion (temporary or permanent) of, or damage to, cerebral arteries during aneurysm surgery, thromboembolism related to turbulent or stagnant aneurysmal blood flow or clip application, and embolism unrelated to SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/89\" class=\"abstract_t\">89</a>].</p><p class=\"headingAnchor\" id=\"H1387166722\"><span class=\"h2\">Hydrocephalus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hydrocephalus is a common complication of SAH. In one large series, hydrocephalus was documented by CT scan in 15 percent of patients, 40 percent of whom were symptomatic [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/113\" class=\"abstract_t\">113</a>]. The clinical presentation of hydrocephalus in this setting is progressive deterioration in level of consciousness, accompanied by ventricular dilation on CT scan. Ocular signs of increased ICP (miosis, downward eye deviation) occur in many but not all patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/114\" class=\"abstract_t\">114</a>].</p><p>Factors associated with an increased risk for hydrocephalus included intraventricular hemorrhage, posterior circulation aneurysms, treatment with antifibrinolytic agents, and a low Glasgow score on presentation. The incidence was also increased in patients with hyponatremia or a history of hypertension. Older age is an additional risk factor.</p><p>Hydrocephalus after SAH is thought to be caused by obstruction of cerebrospinal fluid (CSF) flow by blood products or adhesions, or by a reduction of CSF absorption at the arachnoid granulations [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/115\" class=\"abstract_t\">115</a>]. The former occurs as an acute complication; the latter tends to occur two weeks or later, and is more likely to be associated with shunt dependence.</p><p>Spontaneous improvement occurs in one-half of patients with acute hydrocephalus and impaired consciousness, usually within 24 hours [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/116\" class=\"abstract_t\">116</a>]. In the remainder, acute hydrocephalus is associated with increased morbidity and mortality secondary to rebleeding and cerebral infarction [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/117\" class=\"abstract_t\">117</a>]. Approximately half to two-thirds of patients with acute hydrocephalus after SAH develop chronic shunt-dependent hydrocephalus [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/27\" class=\"abstract_t\">27</a>].</p><p class=\"headingAnchor\" id=\"H1387166728\"><span class=\"h2\">Increased ICP</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with SAH may develop increased intracranial pressure (ICP) due to a number of factors, including hemorrhage volume, acute hydrocephalus, reactive hyperemia after hemorrhage and or ischemia, and distal cerebral arteriolar vasodilation [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/118-121\" class=\"abstract_t\">118-121</a>]. In a series of 234 patients with SAH who had ICP monitoring, increased ICP occurred during the hospital stay in 54 percent, including 49 percent of those considered to have a good clinical grade (Hunt and Hess grades I to III) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/122\" class=\"abstract_t\">122</a>].</p><p class=\"headingAnchor\" id=\"H1387166734\"><span class=\"h2\">Seizures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute seizures occur in 6 to 18 percent of patients with SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/27\" class=\"abstract_t\">27</a>]. Risk factors include thick subarachnoid clot, intracerebral hemorrhage, delayed infarction, and aneurysm in the middle cerebral artery. </p><p>Seizures at the onset of SAH appear to be an independent risk factor for late seizures (epilepsy) and a predictor of poor outcome [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/8,123\" class=\"abstract_t\">8,123</a>]. (See <a href=\"topic.htm?path=treatment-of-aneurysmal-subarachnoid-hemorrhage#H32\" class=\"medical medical_review\">&quot;Treatment of aneurysmal subarachnoid hemorrhage&quot;, section on 'Neurologic morbidity'</a>.) </p><p class=\"headingAnchor\" id=\"H1387166740\"><span class=\"h2\">Hyponatremia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hyponatremia following subarachnoid hemorrhage is relatively common, and is probably mediated by hypothalamic injury. The water retention that leads to hyponatremia is due to increased secretion of antidiuretic hormone, which may result from either the syndrome of inappropriate ADH secretion or, much less often, volume depletion induced by cerebral salt wasting. These issues are discussed separately. (See <a href=\"topic.htm?path=treatment-of-aneurysmal-subarachnoid-hemorrhage#H28\" class=\"medical medical_review\">&quot;Treatment of aneurysmal subarachnoid hemorrhage&quot;, section on 'Hyponatremia'</a> and <a href=\"topic.htm?path=cerebral-salt-wasting\" class=\"medical medical_review\">&quot;Cerebral salt wasting&quot;</a> and <a href=\"topic.htm?path=pathophysiology-and-etiology-of-the-syndrome-of-inappropriate-antidiuretic-hormone-secretion-siadh\" class=\"medical medical_review\">&quot;Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1387166746\"><span class=\"h2\">Cardiac abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of cardiac changes occur after SAH, including ECG changes, structural changes on echocardiography, and acute troponin elevations. These appear to be more common and more severe in those with more severe SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/124,125\" class=\"abstract_t\">124,125</a>]. </p><p><ul class=\"bullet-block\"><li><strong>ECG abnormalities</strong> - The most frequent ECG abnormalities are ST segment depression, QT interval prolongation, deep symmetric T wave inversions, and prominent U waves [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/126\" class=\"abstract_t\">126</a>]. Life-threatening rhythm disturbances such as torsades de pointes have also been described, as well as atrial fibrillation and flutter. ST-T wave abnormalities along with bradycardia and relative tachycardia were found in one large series to be independently associated with mortality [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/126,127\" class=\"abstract_t\">126,127</a>]. Another study reported an association between QT prolongation and angiographic vasospasm. (See <a href=\"topic.htm?path=cardiac-complications-of-stroke\" class=\"medical medical_review\">&quot;Cardiac complications of stroke&quot;</a>.)<br/><br/>The ECG changes are predominantly reflective of ischemic changes in the subendocardium of the left ventricle. The development of actual myocardial injury (in as many as 20 percent of patients) can be established by elevations of CK-MB or serum troponin I (&gt;0.1 <span class=\"nowrap\">&micro;g/L),</span> which is a specific and more sensitive marker of myocardial necrosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/125,128\" class=\"abstract_t\">125,128</a>]. Patients with elevated troponin I concentrations are more likely to have ECG abnormalities and clinical evidence of left ventricular dysfunction. Subendocardial ischemia is an independent predictor of poor outcome in patients with SAH and must be managed aggressively (although without the use of <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/124\" class=\"abstract_t\">124</a>]. (See <a href=\"topic.htm?path=troponin-testing-clinical-use\" class=\"medical medical_review\">&quot;Troponin testing: Clinical use&quot;</a> and <a href=\"topic.htm?path=overview-of-the-acute-management-of-non-st-elevation-acute-coronary-syndromes\" class=\"medical medical_review\">&quot;Overview of the acute management of non-ST elevation acute coronary syndromes&quot;</a>.)</li><li><strong>Left ventricular dysfunction</strong> - A wide spectrum of regional left ventricular wall motion abnormalities, demonstrable by echocardiography, can occur with SAH; these are typically but not always reversible [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/125,129,130\" class=\"abstract_t\">125,129,130</a>]. Heart failure and pulmonary edema can result [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/131\" class=\"abstract_t\">131</a>].<br/><br/>Some patients develop a pattern of transient apical left ventricular dysfunction that mimics myocardial infarction (but in the absence of significant coronary artery disease), a condition known as takotsubo cardiomyopathy, or transient left ventricular apical ballooning syndrome [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/130,132\" class=\"abstract_t\">130,132</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-stress-takotsubo-cardiomyopathy\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy&quot;</a>.)</li><li><strong>Troponin release - </strong>Acute troponin elevation after SAH appears to be associated with increased risk of cardiopulmonary and cerebrovascular complications [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/124,133\" class=\"abstract_t\">124,133</a>]. Elevated peak troponin levels have been associated with an increased risk of left ventricular dysfunction, pulmonary edema, and hypotension requiring pressors as well as with increased mortality and worse functional outcome [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/124\" class=\"abstract_t\">124</a>]. (See <a href=\"topic.htm?path=elevated-cardiac-troponin-concentration-in-the-absence-of-an-acute-coronary-syndrome#H12\" class=\"medical medical_review\">&quot;Elevated cardiac troponin concentration in the absence of an acute coronary syndrome&quot;, section on 'Acute stroke'</a>.)</li><li><strong>Elevated brain type natriuretic peptide </strong>- Elevation of serum brain type natriuretic peptide (BNP) has been noted after SAH [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/124,134,135\" class=\"abstract_t\">124,134,135</a>], although the source of this elevation is unclear. BNP is present in the brain and in the heart; serum BNP elevation occurs with heart failure. (See <a href=\"topic.htm?path=natriuretic-peptide-measurement-in-heart-failure\" class=\"medical medical_review\">&quot;Natriuretic peptide measurement in heart failure&quot;</a>.) <br/><br/>In a prospective cohort of 57 subjects with SAH, elevated BNP levels were associated with the presence of cardiac regional wall motion abnormalities, diastolic dysfunction, pulmonary edema, elevated cardiac troponin I, and left ventricular ejection fraction &lt;50 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/136\" class=\"abstract_t\">136</a>]. These findings suggest that BNP is released from patients with cardiac injury after SAH. A meta-analysis that included almost 3000 patients with SAH found that elevated BNP levels were associated with increased mortality [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/124\" class=\"abstract_t\">124</a>].</li></ul></p><p>Myocardial injury is most likely the result of a centrally mediated release of catecholamines within the myocardium due to hypoperfusion of the posterior hypothalamus. In support of this neurocardiogenic hypothesis, a study of 223 patients with SAH found an incremental and independent relationship between the degree of neurologic injury related to SAH and the probability of elevated serum levels of cardiac troponin [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/137\" class=\"abstract_t\">137</a>]. In contrast to some previous reports, this study found no association between serum levels of catecholamines and troponin levels.</p><p>While the neurocardiogenic hypothesis seems to be the most plausible mechanism, the causes of myocardial damage associated with SAH are likely to be multifactorial and include not only autonomic dysfunction but also factors affecting myocardial oxygen demand, the effect of medications given during treatment, and gender differences [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/138\" class=\"abstract_t\">138</a>]. As an example, one small case series found that hypomagnesemia was present in 37 percent of patients with SAH and was related to a prolongation of the PR interval and a shorter QTc interval [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/139\" class=\"abstract_t\">139</a>]. (See <a href=\"topic.htm?path=significance-of-hypomagnesemia-in-cardiovascular-disease\" class=\"medical medical_review\">&quot;Significance of hypomagnesemia in cardiovascular disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p><ul class=\"bullet-block\"><li>Basics topics (see <a href=\"topic.htm?path=hemorrhagic-stroke-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Hemorrhagic stroke (The Basics)&quot;</a> and <a href=\"topic.htm?path=brain-aneurysm-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Brain aneurysm (The Basics)&quot;</a> and <a href=\"topic.htm?path=subarachnoid-hemorrhage-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Subarachnoid hemorrhage (The Basics)&quot;</a>)</li><li>Beyond the Basics topics (see <a href=\"topic.htm?path=stroke-symptoms-and-diagnosis-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Stroke symptoms and diagnosis (Beyond the Basics)&quot;</a> and <a href=\"topic.htm?path=hemorrhagic-stroke-treatment-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Hemorrhagic stroke treatment (Beyond the Basics)&quot;</a>)</li></ul></p><p class=\"headingAnchor\" id=\"H28752055\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p><ul class=\"bullet-block\"><li>The overwhelming majority of patients with aneurysmal subarachnoid hemorrhage (SAH) present with a sudden onset severe headache which may be associated with brief loss of consciousness, seizures, nausea or vomiting or meningismus. While not invariable, symptom onset may occur in the setting of physical exertion. (See <a href=\"#H12\" class=\"local\">'Clinical presentation'</a> above.)</li><li>Sudden onset of headache, regardless of severity or prior headache history, should raise the clinical suspicion for SAH and compel a diagnostic evaluation. (See <a href=\"#H26\" class=\"local\">'Diagnosis of subarachnoid hemorrhage'</a> above.) </li></ul></p><p><ul class=\"hyphen-block\"><li>Noncontrast head CT reveals the diagnosis in more than 90 percent of cases if performed within 24 hours of bleeding onset. (See <a href=\"#H27\" class=\"local\">'Head CT scan'</a> above.)</li><li>Lumbar puncture is mandatory if there is a strong suspicion of SAH despite a normal head CT. The classic findings are an elevated opening pressure and an elevated red blood cell count that does not diminish from CSF tube one to tube four. Immediate centrifugation of the CSF can help differentiate bleeding in SAH from that due to a traumatic spinal tap. (See <a href=\"#H28\" class=\"local\">'Lumbar puncture'</a> above.)</li></ul></p><p><ul class=\"bullet-block\"><li>Once a diagnosis of SAH has been made, the etiology of the hemorrhage must be determined with vascular imaging. Of the available tests, digital subtraction angiography is believed to have the highest resolution to detect intracranial aneurysms and define their anatomic features and remains the gold standard test for this. (See <a href=\"#H34\" class=\"local\">'Identifying the etiology'</a> above.)</li><li>Repeat angiography is necessary if the initial study is negative, unless the pattern of hemorrhage is perimesencephalic. Additional testing is required for SAH that is nonaneurysmal. (See <a href=\"#H59949337\" class=\"local\">'Patients with negative angiography'</a> above.)</li><li>Complications of SAH include rebleeding, vasospasm and delayed cerebral ischemia, hydrocephalus, increased intracranial pressure, seizures, hyponatremia, cardiac abnormalities, and hypothalamic dysfunction. (See <a href=\"#H1387166640\" class=\"local\">'Complications and clinical course'</a> above.)</li></ul></p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/1\" class=\"nounderline abstract_t\">Ingall TJ, Whisnant JP, Wiebers DO, O'Fallon WM. Has there been a decline in subarachnoid hemorrhage mortality? Stroke 1989; 20:718.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/2\" class=\"nounderline abstract_t\">Truelsen T, Bonita R, Duncan J, et al. Changes in subarachnoid hemorrhage mortality, incidence, and case fatality in New Zealand between 1981-1983 and 1991-1993. Stroke 1998; 29:2298.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/3\" class=\"nounderline abstract_t\">Stegmayr B, Eriksson M, Asplund K. Declining mortality from subarachnoid hemorrhage: changes in incidence and case fatality from 1985 through 2000. Stroke 2004; 35:2059.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/4\" class=\"nounderline abstract_t\">Tidswell P, Dias PS, Sagar HJ, et al. Cognitive outcome after aneurysm rupture: relationship to aneurysm site and perioperative complications. Neurology 1995; 45:875.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/5\" class=\"nounderline abstract_t\">Gorelick PB, Hier DB, Caplan LR, Langenberg P. Headache in acute cerebrovascular disease. Neurology 1986; 36:1445.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/6\" class=\"nounderline abstract_t\">Fontanarosa PB. Recognition of subarachnoid hemorrhage. Ann Emerg Med 1989; 18:1199.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/7\" class=\"nounderline abstract_t\">Schievink WI. Intracranial aneurysms. N Engl J Med 1997; 336:28.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/8\" class=\"nounderline abstract_t\">Butzkueven H, Evans AH, Pitman A, et al. Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 2000; 55:1315.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/9\" class=\"nounderline abstract_t\">Linn FH, Wijdicks EF, van der Graaf Y, et al. Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet 1994; 344:590.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/10\" class=\"nounderline abstract_t\">Morgenstern LB, Luna-Gonzales H, Huber JC Jr, et al. Worst headache and subarachnoid hemorrhage: prospective, modern computed tomography and spinal fluid analysis. Ann Emerg Med 1998; 32:297.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/11\" class=\"nounderline abstract_t\">McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson's syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2004; 75:491.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/12\" class=\"nounderline abstract_t\">Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006; 354:387.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/13\" class=\"nounderline abstract_t\">Polmear A. Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review. Cephalalgia 2003; 23:935.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/14\" class=\"nounderline abstract_t\">Schievink WI, Karemaker JM, Hageman LM, van der Werf DJ. Circumstances surrounding aneurysmal subarachnoid hemorrhage. Surg Neurol 1989; 32:266.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/15\" class=\"nounderline abstract_t\">Fine B, Singh N, Aviv R, Macdonald RL. Decisions: does a patient with a thunderclap headache need a lumbar puncture? CMAJ 2012; 184:555.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/16\" class=\"nounderline abstract_t\">Perry JJ, Spacek A, Forbes M, et al. Is the combination of negative computed tomography result and negative lumbar puncture result sufficient to rule out subarachnoid hemorrhage? Ann Emerg Med 2008; 51:707.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/17\" class=\"nounderline abstract_t\">Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med 2000; 342:29.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/18\" class=\"nounderline abstract_t\">Kowalski RG, Claassen J, Kreiter KT, et al. Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA 2004; 291:866.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/19\" class=\"nounderline abstract_t\">Kassell NF, Kongable GL, Torner JC, et al. Delay in referral of patients with ruptured aneurysms to neurosurgical attention. Stroke 1985; 16:587.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/20\" class=\"nounderline abstract_t\">Vermeulen M, van Gijn J. The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53:365.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/21\" class=\"nounderline abstract_t\">Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990; 73:18.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/22\" class=\"nounderline abstract_t\">Perry JJ, Stiell IG, Sivilotti ML, et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ 2011; 343:d4277.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/23\" class=\"nounderline abstract_t\">Latchaw RE, Silva P, Falcone SF. The role of CT following aneurysmal rupture. Neuroimaging Clin N Am 1997; 7:693.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/24\" class=\"nounderline abstract_t\">van der Wee N, Rinkel GJ, Hasan D, van Gijn J. Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan? J Neurol Neurosurg Psychiatry 1995; 58:357.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/25\" class=\"nounderline abstract_t\">Sidman R, Connolly E, Lemke T. Subarachnoid hemorrhage diagnosis: lumbar puncture is still needed when the computed tomography scan is normal. Acad Emerg Med 1996; 3:827.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/26\" class=\"nounderline abstract_t\">Sames TA, Storrow AB, Finkelstein JA, Magoon MR. Sensitivity of new-generation computed tomography in subarachnoid hemorrhage. Acad Emerg Med 1996; 3:16.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/27\" class=\"nounderline abstract_t\">Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012; 43:1711.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/28\" class=\"nounderline abstract_t\">Backes D, Rinkel GJ, Kemperman H, et al. Time-dependent test characteristics of head computed tomography in patients suspected of nontraumatic subarachnoid hemorrhage. Stroke 2012; 43:2115.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/29\" class=\"nounderline abstract_t\">Edlow JA, Fisher J. Diagnosis of subarachnoid hemorrhage: time to change the guidelines? Stroke 2012; 43:2031.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/30\" class=\"nounderline abstract_t\">Leblanc R. The minor leak preceding subarachnoid hemorrhage. J Neurosurg 1987; 66:35.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/31\" class=\"nounderline abstract_t\">van der Jagt M, Hasan D, Bijvoet HW, et al. Validity of prediction of the site of ruptured intracranial aneurysms with CT. Neurology 1999; 52:34.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/32\" class=\"nounderline abstract_t\">Wiesmann M, Mayer TE, Yousry I, et al. Detection of hyperacute subarachnoid hemorrhage of the brain by using magnetic resonance imaging. J Neurosurg 2002; 96:684.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/33\" class=\"nounderline abstract_t\">Mitchell P, Wilkinson ID, Hoggard N, et al. Detection of subarachnoid haemorrhage with magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2001; 70:205.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/34\" class=\"nounderline abstract_t\">Mark DG, Hung YY, Offerman SR, et al. Nontraumatic subarachnoid hemorrhage in the setting of negative cranial computed tomography results: external validation of a clinical and imaging prediction rule. Ann Emerg Med 2013; 62:1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/35\" class=\"nounderline abstract_t\">Heasley DC, Mohamed MA, Yousem DM. Clearing of red blood cells in lumbar puncture does not rule out ruptured aneurysm in patients with suspected subarachnoid hemorrhage but negative head CT findings. AJNR Am J Neuroradiol 2005; 26:820.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/36\" class=\"nounderline abstract_t\">Czuczman AD, Thomas LE, Boulanger AB, et al. Interpreting red blood cells in lumbar puncture: distinguishing true subarachnoid hemorrhage from traumatic tap. Acad Emerg Med 2013; 20:247.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/37\" class=\"nounderline abstract_t\">Wijdicks EF, Kallmes DF, Manno EM, et al. Subarachnoid hemorrhage: neurointensive care and aneurysm repair. Mayo Clin Proc 2005; 80:550.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/38\" class=\"nounderline abstract_t\">Wallace AN, Dines JN, Zipfel GJ, Derdeyn CP. Yield of catheter angiography after computed tomography negative, lumbar puncture positive subarachnoid hemorrhage [corrected]. Stroke 2013; 44:1729.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/39\" class=\"nounderline abstract_t\">UK National External Quality Assessment Scheme for Immunochemistry Working Group. National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem 2003; 40:481.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/40\" class=\"nounderline abstract_t\">Vermeulen M, Hasan D, Blijenberg BG, et al. Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry 1989; 52:826.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/41\" class=\"nounderline abstract_t\">Dupont SA, Wijdicks EF, Manno EM, Rabinstein AA. Thunderclap headache and normal computed tomographic results: value of cerebrospinal fluid analysis. Mayo Clin Proc 2008; 83:1326.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/42\" class=\"nounderline abstract_t\">Vermeulen M, van Gijn J, Blijenberg BG. Spectrophotometric analysis of CSF after subarachnoid hemorrhage: limitations in the diagnosis of rebleeding. Neurology 1983; 33:112.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/43\" class=\"nounderline abstract_t\">Cruickshank A, Beetham R, Holbrook I, et al. Spectrophotometry of cerebrospinal fluid in suspected subarachnoid haemorrhage. BMJ 2005; 330:138.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/44\" class=\"nounderline abstract_t\">Beetham R, UK NEQAS for Immunochermistry Working group. Recommendations for CSF analysis in subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2004; 75:528.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/45\" class=\"nounderline abstract_t\">Petzold A, Keir G, Sharpe TL. Why human color vision cannot reliably detect cerebrospinal fluid xanthochromia. Stroke 2005; 36:1295.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/46\" class=\"nounderline abstract_t\">Sidman R, Spitalnic S, Demelis M, et al. Xanthrochromia? By what method? A comparison of visual and spectrophotometric xanthrochromia. Ann Emerg Med 2005; 46:51.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/47\" class=\"nounderline abstract_t\">Perry JJ, Sivilotti ML, Stiell IG, et al. Should spectrophotometry be used to identify xanthochromia in the cerebrospinal fluid of alert patients suspected of having subarachnoid hemorrhage? Stroke 2006; 37:2467.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/48\" class=\"nounderline abstract_t\">Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40:994.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/49\" class=\"nounderline abstract_t\">Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: a meta-analysis. Stroke 1999; 30:317.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/50\" class=\"nounderline abstract_t\">Li MH, Cheng YS, Li YD, et al. Large-cohort comparison between three-dimensional time-of-flight magnetic resonance and rotational digital subtraction angiographies in intracranial aneurysm detection. Stroke 2009; 40:3127.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/51\" class=\"nounderline abstract_t\">Villablanca JP, Hooshi P, Martin N, et al. Three-dimensional helical computerized tomography angiography in the diagnosis, characterization, and management of middle cerebral artery aneurysms: comparison with conventional angiography and intraoperative findings. J Neurosurg 2002; 97:1322.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/52\" class=\"nounderline abstract_t\">Chappell ET, Moure FC, Good MC. Comparison of computed tomographic angiography with digital subtraction angiography in the diagnosis of cerebral aneurysms: a meta-analysis. Neurosurgery 2003; 52:624.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/53\" class=\"nounderline abstract_t\">Wintermark M, Uske A, Chalaron M, et al. Multislice computerized tomography angiography in the evaluation of intracranial aneurysms: a comparison with intraarterial digital subtraction angiography. J Neurosurg 2003; 98:828.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/54\" class=\"nounderline abstract_t\">Colen TW, Wang LC, Basavaraj BV, et al. Effectiveness of MDCT angiography for the detection of intracranial aneurysms in patients with nontraumatic subarachnoid hemorrhage. AJR Am J Roentgenol 2007; 189:898.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/55\" class=\"nounderline abstract_t\">Papke K, Kuhl CK, Fruth M, et al. Intracranial aneurysms: role of multidetector CT angiography in diagnosis and endovascular therapy planning. Radiology 2007; 244:532.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/56\" class=\"nounderline abstract_t\">Li Q, Lv F, Li Y, et al. Evaluation of 64-section CT angiography for detection and treatment planning of intracranial aneurysms by using DSA and surgical findings. Radiology 2009; 252:808.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/57\" class=\"nounderline abstract_t\">Lu L, Zhang LJ, Poon CS, et al. Digital subtraction CT angiography for detection of intracranial aneurysms: comparison with three-dimensional digital subtraction angiography. Radiology 2012; 262:605.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/58\" class=\"nounderline abstract_t\">van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007; 369:306.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/59\" class=\"nounderline abstract_t\">Menke J, Larsen J, Kallenberg K. Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis. Ann Neurol 2011; 69:646.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/60\" class=\"nounderline abstract_t\">Westerlaan HE, van Dijk JM, Jansen-van der Weide MC, et al. Intracranial aneurysms in patients with subarachnoid hemorrhage: CT angiography as a primary examination tool for diagnosis--systematic review and meta-analysis. Radiology 2011; 258:134.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/61\" class=\"nounderline abstract_t\">Velthuis BK, Van Leeuwen MS, Witkamp TD, et al. Computerized tomography angiography in patients with subarachnoid hemorrhage: from aneurysm detection to treatment without conventional angiography. J Neurosurg 1999; 91:761.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/62\" class=\"nounderline abstract_t\">Villablanca JP, Martin N, Jahan R, et al. Volume-rendered helical computerized tomography angiography in the detection and characterization of intracranial aneurysms. J Neurosurg 2000; 93:254.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/63\" class=\"nounderline abstract_t\">Brouwers HB, Backes D, Kimberly WT, et al. Computed tomography angiography spot sign does not predict case fatality in aneurysmal subarachnoid hemorrhage with intraparenchymal extension. Stroke 2013; 44:1590.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/64\" class=\"nounderline abstract_t\">Delgado Almandoz JE, Kelly HR, Schaefer PW, et al. CT angiography spot sign predicts in-hospital mortality in patients with secondary intracerebral hemorrhage. J Neurointerv Surg 2012; 4:442.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/65\" class=\"nounderline abstract_t\">Tatter SB, Crowell RM, Ogilvy CS. Aneurysmal and microaneurysmal &quot;angiogram-negative&quot; subarachnoid hemorrhage. Neurosurgery 1995; 37:48.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/66\" class=\"nounderline abstract_t\">Jung JY, Kim YB, Lee JW, et al. Spontaneous subarachnoid haemorrhage with negative initial angiography: a review of 143 cases. J Clin Neurosci 2006; 13:1011.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/67\" class=\"nounderline abstract_t\">Rinkel GJ, van Gijn J, Wijdicks EF. Subarachnoid hemorrhage without detectable aneurysm. A review of the causes. Stroke 1993; 24:1403.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/68\" class=\"nounderline abstract_t\">Urbach H, Zentner J, Solymosi L. The need for repeat angiography in subarachnoid haemorrhage. Neuroradiology 1998; 40:6.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/69\" class=\"nounderline abstract_t\">du Mesnil de Rochemont R, Heindel W, Wesselmann C, et al. Nontraumatic subarachnoid hemorrhage: value of repeat angiography. Radiology 1997; 202:798.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/70\" class=\"nounderline abstract_t\">Schwartz TH, Solomon RA. Perimesencephalic nonaneurysmal subarachnoid hemorrhage: review of the literature. Neurosurgery 1996; 39:433.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/71\" class=\"nounderline abstract_t\">Rinkel GJ, Wijdicks EF, Hasan D, et al. Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991; 338:964.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/72\" class=\"nounderline abstract_t\">van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A. Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 1985; 35:493.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/73\" class=\"nounderline abstract_t\">Rinkel GJ, Wijdicks EF, Vermeulen M, et al. The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol 1991; 29:463.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/74\" class=\"nounderline abstract_t\">Velthuis BK, Rinkel GJ, Ramos LM, et al. Perimesencephalic hemorrhage. Exclusion of vertebrobasilar aneurysms with CT angiography. Stroke 1999; 30:1103.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/75\" class=\"nounderline abstract_t\">Ruigrok YM, Rinkel GJ, Buskens E, et al. Perimesencephalic hemorrhage and CT angiography: A decision analysis. Stroke 2000; 31:2976.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/76\" class=\"nounderline abstract_t\">Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997; 28:660.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/77\" class=\"nounderline abstract_t\">Broderick JP, Brott TG, Duldner JE, et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994; 25:1342.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/78\" class=\"nounderline abstract_t\">Winn HR, Richardson AE, Jane JA. The long-term prognosis in untreated cerebral aneurysms: I. The incidence of late hemorrhage in cerebral aneurysm: a 10-year evaluation of 364 patients. Ann Neurol 1977; 1:358.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/79\" class=\"nounderline abstract_t\">Inagawa T, Kamiya K, Ogasawara H, Yano T. Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol 1987; 28:93.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/80\" class=\"nounderline abstract_t\">Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol 2005; 62:410.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/81\" class=\"nounderline abstract_t\">Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg 2013; 79:307.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/82\" class=\"nounderline abstract_t\">Lord AS, Fernandez L, Schmidt JM, et al. Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage. Neurology 2012; 78:31.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/83\" class=\"nounderline abstract_t\">Beck J, Raabe A, Szelenyi A, et al. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke 2006; 37:2733.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/84\" class=\"nounderline abstract_t\">Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25:2315.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/85\" class=\"nounderline abstract_t\">Haley EC Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1993; 78:537.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/86\" class=\"nounderline abstract_t\">Haley EC Jr, Kassell NF, Torner JC, et al. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 1994; 80:788.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/87\" class=\"nounderline abstract_t\">Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF. Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2005; 36:992.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/88\" class=\"nounderline abstract_t\">Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6:1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/89\" class=\"nounderline abstract_t\">Juvela S, Siironen J, Varis J, et al. Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage. J Neurosurg 2005; 102:194.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/90\" class=\"nounderline abstract_t\">Crobeddu E, Mittal MK, Dupont S, et al. Predicting the lack of development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 2012; 43:697.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/91\" class=\"nounderline abstract_t\">de Rooij NK, Greving JP, Rinkel GJ, Frijns CJ. Early prediction of delayed cerebral ischemia after subarachnoid hemorrhage: development and validation of a practical risk chart. Stroke 2013; 44:1288.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/92\" class=\"nounderline abstract_t\">de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke 2013; 44:43.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/93\" class=\"nounderline abstract_t\">Schmidt JM, Wartenberg KE, Fernandez A, et al. Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg 2008; 109:1052.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/94\" class=\"nounderline abstract_t\">Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004; 35:1862.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/95\" class=\"nounderline abstract_t\">Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16:562.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/96\" class=\"nounderline abstract_t\">Kreiter KT, Mayer SA, Howard G, et al. Sample size estimates for clinical trials of vasospasm in subarachnoid hemorrhage. Stroke 2009; 40:2362.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/97\" class=\"nounderline abstract_t\">Wilkins RH. Aneurysm rupture during angiography: does acute vasospasm occur? Surg Neurol 1976; 5:299.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/98\" class=\"nounderline abstract_t\">Bederson JB, Levy AL, Ding WH, et al. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 1998; 42:352.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/99\" class=\"nounderline abstract_t\">Qureshi AI, Sung GY, Suri MA, et al. Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1999; 44:967.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/100\" class=\"nounderline abstract_t\">Baldwin ME, Macdonald RL, Huo D, et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004; 35:2506.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/101\" class=\"nounderline abstract_t\">Weisberg LA. Computed tomography in aneurysmal subarachnoid hemorrhage. Neurology 1979; 29:802.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/102\" class=\"nounderline abstract_t\">Kistler JP, Crowell RM, Davis KR, et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 1983; 33:424.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/103\" class=\"nounderline abstract_t\">Ko SB, Choi HA, Carpenter AM, et al. Quantitative analysis of hemorrhage volume for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Stroke 2011; 42:669.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/104\" class=\"nounderline abstract_t\">Charpentier C, Audibert G, Guillemin F, et al. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 1999; 30:1402.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/105\" class=\"nounderline abstract_t\">Badjatia N, Topcuoglu MA, Buonanno FS, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med 2005; 33:1603.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/106\" class=\"nounderline abstract_t\">Hop JW, Rinkel GJ, Algra A, van Gijn J. Initial loss of consciousness and risk of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Stroke 1999; 30:2268.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/107\" class=\"nounderline abstract_t\">Qureshi AI, Sung GY, Razumovsky AY, et al. Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med 2000; 28:984.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/108\" class=\"nounderline abstract_t\">Singhal AB, Topcuoglu MA, Dorer DJ, et al. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 2005; 64:1008.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/109\" class=\"nounderline abstract_t\">Ibrahim GM, Weidauer S, Vatter H, et al. Attributing hypodensities on CT to angiographic vasospasm is not sensitive and unreliable. Stroke 2012; 43:109.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/110\" class=\"nounderline abstract_t\">Hoff R, Rinkel G, Verweij B, et al. Blood volume measurement to guide fluid therapy after aneurysmal subarachnoid hemorrhage: a prospective controlled study. Stroke 2009; 40:2575.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/111\" class=\"nounderline abstract_t\">Jaeger M, Soehle M, Schuhmann MU, Meixensberger J. Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage. Stroke 2012; 43:2097.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/112\" class=\"nounderline abstract_t\">Budohoski KP, Czosnyka M, Smielewski P, et al. Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study. Stroke 2012; 43:3230.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/113\" class=\"nounderline abstract_t\">Graff-Radford NR, Torner J, Adams HP Jr, Kassell NF. Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol 1989; 46:744.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/114\" class=\"nounderline abstract_t\">van Gijn J, Hijdra A, Wijdicks EF, et al. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg 1985; 63:355.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/115\" class=\"nounderline abstract_t\">Douglas MR, Daniel M, Lagord C, et al. High CSF transforming growth factor beta levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus. J Neurol Neurosurg Psychiatry 2009; 80:545.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/116\" class=\"nounderline abstract_t\">Hasan D, Vermeulen M, Wijdicks EF, et al. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke 1989; 20:747.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/117\" class=\"nounderline abstract_t\">Suarez-Rivera O. Acute hydrocephalus after subarachnoid hemorrhage. Surg Neurol 1998; 49:563.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/118\" class=\"nounderline abstract_t\">Nornes H, Magnaes B. Intracranial pressure in patients with ruptured saccular aneurysm. J Neurosurg 1972; 36:537.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/119\" class=\"nounderline abstract_t\">Par&eacute; L, Delfino R, Leblanc R. The relationship of ventricular drainage to aneurysmal rebleeding. J Neurosurg 1992; 76:422.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/120\" class=\"nounderline abstract_t\">Brinker T, Seifert V, Stolke D. Acute changes in the dynamics of the cerebrospinal fluid system during experimental subarachnoid hemorrhage. Neurosurgery 1990; 27:369.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/121\" class=\"nounderline abstract_t\">Heinsoo M, Eelm&auml;e J, Kuklane M, et al. The possible role of CSF hydrodynamic parameters following in management of SAH patients. Acta Neurochir Suppl 1998; 71:13.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/122\" class=\"nounderline abstract_t\">Heuer GG, Smith MJ, Elliott JP, et al. Relationship between intracranial pressure and other clinical variables in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2004; 101:408.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/123\" class=\"nounderline abstract_t\">Claassen J, Peery S, Kreiter KT, et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 2003; 60:208.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/124\" class=\"nounderline abstract_t\">van der Bilt IA, Hasan D, Vandertop WP, et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 2009; 72:635.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/125\" class=\"nounderline abstract_t\">Hravnak M, Frangiskakis JM, Crago EA, et al. Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke 2009; 40:3478.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/126\" class=\"nounderline abstract_t\">Junttila E, Vaara M, Koskenkari J, et al. Repolarization abnormalities in patients with subarachnoid and intracerebral hemorrhage: predisposing factors and association with outcome. Anesth Analg 2013; 116:190.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/127\" class=\"nounderline abstract_t\">Coghlan LA, Hindman BJ, Bayman EO, et al. Independent associations between electrocardiographic abnormalities and outcomes in patients with aneurysmal subarachnoid hemorrhage: findings from the intraoperative hypothermia aneurysm surgery trial. Stroke 2009; 40:412.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/128\" class=\"nounderline abstract_t\">Parekh N, Venkatesh B, Cross D, et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000; 36:1328.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/129\" class=\"nounderline abstract_t\">Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke 1999; 30:780.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/130\" class=\"nounderline abstract_t\">Lee VH, Connolly HM, Fulgham JR, et al. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 2006; 105:264.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/131\" class=\"nounderline abstract_t\">Yoneda H, Nakamura T, Shirao S, et al. Multicenter prospective cohort study on volume management after subarachnoid hemorrhage: hemodynamic changes according to severity of subarachnoid hemorrhage and cerebral vasospasm. Stroke 2013; 44:2155.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/132\" class=\"nounderline abstract_t\">Hakeem A, Marks AD, Bhatti S, Chang SM. When the worst headache becomes the worst heartache! Stroke 2007; 38:3292.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/133\" class=\"nounderline abstract_t\">Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 2005; 112:2851.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/134\" class=\"nounderline abstract_t\">Masuda T, Sato K, Yamamoto S, et al. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke 2002; 33:1671.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/135\" class=\"nounderline abstract_t\">Crago EA, Kerr ME, Kong Y, et al. The impact of cardiac complications on outcome in the SAH population. Acta Neurol Scand 2004; 110:248.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/136\" class=\"nounderline abstract_t\">Tung PP, Olmsted E, Kopelnik A, et al. Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke 2005; 36:1567.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/137\" class=\"nounderline abstract_t\">Tung P, Kopelnik A, Banki N, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004; 35:548.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/138\" class=\"nounderline abstract_t\">Homma S, Grahame-Clarke C. Editorial comment--myocardial damage in patients with subarachnoid hemorrhage. Stroke 2004; 35:552.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-aneurysmal-subarachnoid-hemorrhage/abstract/139\" class=\"nounderline abstract_t\">van den Bergh WM, Algra A, Rinkel GJ. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke 2004; 35:644.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1130 Version 15.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H28752055\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">CLINICAL PRESENTATION</a></li><li><a href=\"#H26\" id=\"outline-link-H26\">DIAGNOSIS OF SUBARACHNOID HEMORRHAGE</a><ul><li><a href=\"#H27\" id=\"outline-link-H27\">Head CT scan</a></li><li><a href=\"#H1387169153\" id=\"outline-link-H1387169153\">Brain MRI</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">Lumbar puncture</a></li><li><a href=\"#H1412261260\" id=\"outline-link-H1412261260\">Differential diagnosis</a></li></ul></li><li><a href=\"#H34\" id=\"outline-link-H34\">IDENTIFYING THE ETIOLOGY</a><ul><li><a href=\"#H35\" id=\"outline-link-H35\">Digital subtraction angiography</a></li><li><a href=\"#H36\" id=\"outline-link-H36\">CT and MR angiography</a></li><li><a href=\"#H59949337\" id=\"outline-link-H59949337\">Patients with negative angiography</a><ul><li><a href=\"#H59950365\" id=\"outline-link-H59950365\">- Repeat angiography</a></li><li><a href=\"#H37\" id=\"outline-link-H37\">- Perimesencephalic hemorrhage</a></li><li><a href=\"#H38\" id=\"outline-link-H38\">- Other tests</a></li></ul></li></ul></li><li><a href=\"#H1387169359\" id=\"outline-link-H1387169359\">GRADING SEVERITY</a></li><li><a href=\"#H1387166640\" id=\"outline-link-H1387166640\">COMPLICATIONS AND CLINICAL COURSE</a><ul><li><a href=\"#H1387166686\" id=\"outline-link-H1387166686\">Rebleeding</a></li><li><a href=\"#H1387166692\" id=\"outline-link-H1387166692\">Vasospasm and delayed cerebral ischemia</a></li><li><a href=\"#H1387166722\" id=\"outline-link-H1387166722\">Hydrocephalus</a></li><li><a href=\"#H1387166728\" id=\"outline-link-H1387166728\">Increased ICP</a></li><li><a href=\"#H1387166734\" id=\"outline-link-H1387166734\">Seizures</a></li><li><a href=\"#H1387166740\" id=\"outline-link-H1387166740\">Hyponatremia</a></li><li><a href=\"#H1387166746\" id=\"outline-link-H1387166746\">Cardiac abnormalities</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H39\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H28752055\" id=\"outline-link-H28752055\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"NEURO/1130|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=NEURO/72476\" class=\"graphic graphic_diagnosticimage\">- CT perimesencephalic nonaneurysmal SAH</a></li></ul></li><li><div id=\"NEURO/1130|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=NEURO/69179\" class=\"graphic graphic_table\">- Hunt and Hess grading system</a></li><li><a href=\"image.htm?imageKey=NEURO/81710\" class=\"graphic graphic_table\">- Etiologies of thunderclap headache</a></li><li><a href=\"image.htm?imageKey=NEURO/65468\" class=\"graphic graphic_table\">- WFNS SAH grading scale</a></li><li><a href=\"image.htm?imageKey=NEURO/81854\" class=\"graphic graphic_table\">- Glasgow Coma Scale (GCS)</a></li><li><a href=\"image.htm?imageKey=NEURO/81122\" class=\"graphic graphic_table\">- Fisher SAH CT grading scale</a></li><li><a href=\"image.htm?imageKey=NEURO/57558\" class=\"graphic graphic_table\">- Claassen SAH CT grading scale</a></li><li><a href=\"image.htm?imageKey=NEURO/70705\" class=\"graphic graphic_table\">- Ogilvy Carter grading system</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=aneurysmal-subarachnoid-hemorrhage-epidemiology-risk-factors-and-pathogenesis\" class=\"medical medical_review\">Aneurysmal subarachnoid hemorrhage: Epidemiology, risk factors, and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-thunderclap-headache\" class=\"medical medical_review\">Approach to the patient with thunderclap headache</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiac-complications-of-stroke\" class=\"medical medical_review\">Cardiac complications of stroke</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cerebral-salt-wasting\" class=\"medical medical_review\">Cerebral salt wasting</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cerebrospinal-fluid-physiology-and-utility-of-an-examination-in-disease-states\" class=\"medical medical_review\">Cerebrospinal fluid: Physiology and utility of an examination in disease states</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-stress-takotsubo-cardiomyopathy\" class=\"medical medical_review\">Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=elevated-cardiac-troponin-concentration-in-the-absence-of-an-acute-coronary-syndrome\" class=\"medical medical_review\">Elevated cardiac troponin concentration in the absence of an acute coronary syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=natriuretic-peptide-measurement-in-heart-failure\" class=\"medical medical_review\">Natriuretic peptide measurement in heart failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nonaneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">Nonaneurysmal subarachnoid hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-infected-mycotic-arterial-aneurysm\" class=\"medical medical_review\">Overview of infected (mycotic) arterial aneurysm</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-acute-management-of-non-st-elevation-acute-coronary-syndromes\" class=\"medical medical_review\">Overview of the acute management of non-ST elevation acute coronary syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-and-etiology-of-the-syndrome-of-inappropriate-antidiuretic-hormone-secretion-siadh\" class=\"medical medical_review\">Pathophysiology and etiology of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=brain-aneurysm-the-basics\" class=\"medical medical_basics\">Patient education: Brain aneurysm (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hemorrhagic-stroke-the-basics\" class=\"medical medical_basics\">Patient education: Hemorrhagic stroke (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hemorrhagic-stroke-treatment-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Hemorrhagic stroke treatment (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stroke-symptoms-and-diagnosis-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Stroke symptoms and diagnosis (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=subarachnoid-hemorrhage-the-basics\" class=\"medical medical_basics\">Patient education: Subarachnoid hemorrhage (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=perimesencephalic-nonaneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">Perimesencephalic nonaneurysmal subarachnoid hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=significance-of-hypomagnesemia-in-cardiovascular-disease\" class=\"medical medical_review\">Significance of hypomagnesemia in cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=subarachnoid-hemorrhage-grading-scales\" class=\"medical medical_review\">Subarachnoid hemorrhage grading scales</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-aneurysmal-subarachnoid-hemorrhage\" class=\"medical medical_review\">Treatment of aneurysmal subarachnoid hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=troponin-testing-clinical-use\" class=\"medical medical_review\">Troponin testing: Clinical use</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=unruptured-intracranial-aneurysms\" class=\"medical medical_review\">Unruptured intracranial aneurysms</a></li></ul></div></div>","javascript":null}